MASITINIB FOR THE TREATMENT OF A MULTIPLE SCLEROSIS PATIENT SUBPOPULATION Application WO-2021165472-A1 World Intellectual Property Organisation (WIPO) 26 Aug 2021
Treatment of eosinophil or mast cell related disorders Grant US-10774146-B2 United States of America 15 Sep 2020
PROCESS FOR PREPARING SUBSTITUTED 2,3-DIHYDRO-1H-INDEN-1-ONE RETINOIC ACID-RELATED ORPHAN… Application EP-3680237-A1 European Patent Office 15 Jul 2020
Treatment of eosinophil or mast cell related disorders Grant US-10239943-B2 United States of America 26 Mar 2019